The combination of the high selectivity of antibodies and the high potency of small molecules has led to a new era of cancer therapies.
Antibody-drug Conjudates Development
创建: Oct 11, 2018 | 09:40
array(2) { ["lab"]=> string(3) "621" ["research"]=> string(3) "895" }
The combination of the high selectivity of antibodies and the high potency of small molecules has led to a new era of cancer therapies.